GK
MDT icon

Graney & King’s Medtronic MDT Stock Holding History

Graney & King’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14.1K Buy
181
+2
+1% +$161 0.01% 231
2026
Q1 		$15.5K Buy
179
+1
+0.6% +$96 0.01% 215
2025
Q4 		$17.1K Buy
178
+1
+0.6% +$97 0.01% 205
2025
Q3 		$16.8K Buy
177
+2
+1% +$184 0.01% 197
2025
Q2 		$15.3K Buy
175
+1
+0.6% +$85 0.01% 198
2025
Q1 		$15.6K Buy
174
+2
+1% +$179 0.01% 191
2024
Q4 		$13.8K Buy
+172
New +$14.9K 0.01% 194

Other funds holding MDT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Graney & King's MDT Position: Q2 2026 in Review

Graney & King increased its Medtronic (MDT) stake by 1.1% in Q2 2026, buying an estimated $161 and bringing the position to 181 shares worth $14.1K. The position accounts for 0.01% of the portfolio, ranked #231.

Graney & King first reported a position in MDT in Q4 2024 and has held it in 7 quarters since. The position peaked at $17.1K in Q4 2025. 2,134 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Graney & King held 181 shares of Medtronic worth $14.1K as of Q2 2026.
  • Graney & King bought 2 Medtronic shares in Q2 2026, an estimated $161.
  • Medtronic made up 0.01% of Graney & King's portfolio in Q2 2026, its #231 holding.
  • Graney & King first reported a position in Medtronic in Q4 2024 and has held it in 7 quarters since.
  • Graney & King's Medtronic position peaked at $17.1K in Q4 2025.
  • 2,134 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Graney & King's 13F filing for Q2 2026, filed 7 Aug 2026.